Indo National acquires additional 0.78% stake in Medcuore Medical
- Indo National increased its stake in Medcuore Medical Solutions by 0.78% for ₹50.04 lakh
- Total shareholding in the air monitoring firm now stands at 61.87%
- MMSPL reported FY26 turnover of ₹1.46 crore, up from ₹35.4 lakh in FY25
- The acquisition involves 329 equity shares bought via cash subscription
- No related-party interests or regulatory approvals were involved
*this image is generated using AI for illustrative purposes only.
Indo National acquired an additional 0.78% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹50,03,864 on September 2, 2026. The transaction increases the company’s total shareholding in the air monitoring systems firm to 61.87%.
The investment was made through a cash subscription to equity shares, based on valuation reports issued by a registered valuer. The acquisition is not classified as a related-party transaction, and no promoters or group companies hold an interest in MMSPL.
Transaction Details
Indo National purchased 329 equity shares in two tranches during 2026:
- 153 shares at ₹16,536 per share, based on a valuation report dated May 16, 2026.
- 176 shares at ₹14,056 per share, based on a valuation report dated August 21, 2026.
The company disclosed the move under Regulation 30 of the SEBI LODR regulations. No governmental or regulatory approvals were required for the acquisition.
Target Entity Profile
Medcuore Medical Solutions Private Ltd is engaged in the manufacturing, distribution, and servicing of air monitoring systems and air purifiers. Incorporated on June 7, 2020, the entity operates exclusively in India.
| Fiscal Year | Turnover |
|---|---|
| FY26 | ₹1,45,60,000 |
| FY25 | ₹35,41,484 |
| FY24 | ₹47,68,000 |
MMSPL’s turnover rose significantly in FY26 compared to FY25, following a dip in FY24. The company stated that the acquisition aims to facilitate business growth and generate revenue through expansion.
What the Numbers Show
The divergence in per-share pricing between the May and August tranches indicates a lower valuation basis for the later purchase. The August tranche price of ₹14,056 was approximately 15% lower than the May price of ₹16,536, suggesting a adjustment in the target’s valuation metrics between the two reporting dates.
Historical Stock Returns for Indo National
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.51% | -0.46% | +0.23% | -3.97% | -31.32% | -37.23% |
How does the 15% valuation drop between May and August tranches reflect changing market conditions or specific operational challenges at MMSPL?
What is Indo National's strategic roadmap for integrating MMSPL's air monitoring technology into its existing product portfolio to drive synergies?
Given MMSPL's exclusive focus on the Indian market, what are the plans for geographic expansion or diversification into international markets post-acquisition?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
